furazolidone has been researched along with Duodenal Ulcer in 26 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis." | 9.12 | Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006) |
| "To evaluate the efficacy of omeprazole plus clarithromycin and furazolidone in Helicobacter pylori eradication and duodenal ulcer healing in Brazilian patients." | 9.09 | Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. ( Cabral, MM; Dani, R; De Castro, LP; Dias, MG; Franco, JM; Magalhães, LC; Mendes, GS; Moreira, LS; Queiroz, DM; Rocha, GA; Salles, PG; Toppa, NH, 1999) |
| "The histamine concentration of the oxyntic mucosa was determined in Helicobacter pylori-positive patients with duodenal ulcer before and after antimicrobial therapy and in H." | 7.68 | Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication. ( Coelho, LG; Cunha-Melo, JR; Lima Júnior, GF; Mendes, EN; Moura, SB; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "The present experiments examined the protective effect of the nitrofuran drugs, furazolidone (FZ) and nitrofurazone (NF), on duodenal ulceration induced by cysteamine or indometacin in rats." | 7.68 | Effect of nitrofurans on duodenal ulceration induced by cysteamine or indometacin. ( Ali, BH, 1991) |
| "Wei-Yan-Ning and Furazolidone were used separately in the treatment of 62 cases of gastritis and gastric ulcer caused by pyloric campylobacteria." | 7.67 | [Comparative study of the effect of wei-yan-ning and furazolidone in the treatment of gastritis and gastric ulcer caused by pyloric Campylobacter]. ( Song, XR; Zhang, BM, 1989) |
| "The effect of furazolidone, a monoamine oxidase (MAO) inhibitor, on cysteamine-induced duodenal ulcer and gut catecholamines was studied in rats, since previous reports have suggested protective effects of MAO inhibitors against other forms of experimental mucosal injury." | 7.67 | Effect of furazolidone on gut catecholamine in cysteamine-induced duodenal ulcer in the rat. ( Xing, LP; Zheng, ZT, 1988) |
| "Furazolidone was tried in several developing countries and showed good results in some trials." | 5.37 | To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients. ( Hasan, M; Islam, N; Masud, H; Raihan, AS; Roy, PK; Saha, SK, 2011) |
| "To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis." | 5.12 | Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006) |
| "To evaluate the efficacy of omeprazole plus clarithromycin and furazolidone in Helicobacter pylori eradication and duodenal ulcer healing in Brazilian patients." | 5.09 | Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. ( Cabral, MM; Dani, R; De Castro, LP; Dias, MG; Franco, JM; Magalhães, LC; Mendes, GS; Moreira, LS; Queiroz, DM; Rocha, GA; Salles, PG; Toppa, NH, 1999) |
| "In order to explore the optimal regimens for the eradication of Helicobacter pylori (Hp), eighty-eight patients with duodenal ulcer (DU) or non-ulcer dyspepsia and Hp infection, defined by culture and histology, received the one-week triple therapy with clarithromycin (Cla), furazolidone (Fur) plus lansoprazole (Lan) or colloidal bismuth subcitrate (CBS)." | 5.08 | [Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. ( Liu, W; Lü, B; Xiao, S, 1996) |
| " Helicobacter pylori status and the histology of the antral and oxyntic mucosa were evaluated in 25 patients with duodenal ulcer treated with a triple schedule of furazolidone, metronidazole and amoxicillin, and in 16 patients treated only with cimetidine." | 3.68 | Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori. ( Barbosa, AJ; Castro, LP; Coelho, LG; Lima Júnior, GF; Mendes, EN; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "The histamine concentration of the oxyntic mucosa was determined in Helicobacter pylori-positive patients with duodenal ulcer before and after antimicrobial therapy and in H." | 3.68 | Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication. ( Coelho, LG; Cunha-Melo, JR; Lima Júnior, GF; Mendes, EN; Moura, SB; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "Forty-eight patients with endoscopically proven duodenal ulcer (DU) and Helicobacter pylori infection detected by 14C-urea breath test (BT) were assigned to 5 days of treatment with furazolidone, metronidazole, and amoxicillin in addition to eventual classical anti-ulcer agents if necessary." | 3.68 | Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. ( Brandao, MJ; Castro, LP; Chausson, Y; Coelho, LG; Costa, EL; Maia, AF; Passos, MC; Rodrigues, DC, 1992) |
| "The present experiments examined the protective effect of the nitrofuran drugs, furazolidone (FZ) and nitrofurazone (NF), on duodenal ulceration induced by cysteamine or indometacin in rats." | 3.68 | Effect of nitrofurans on duodenal ulceration induced by cysteamine or indometacin. ( Ali, BH, 1991) |
| "Wei-Yan-Ning and Furazolidone were used separately in the treatment of 62 cases of gastritis and gastric ulcer caused by pyloric campylobacteria." | 3.67 | [Comparative study of the effect of wei-yan-ning and furazolidone in the treatment of gastritis and gastric ulcer caused by pyloric Campylobacter]. ( Song, XR; Zhang, BM, 1989) |
| "The purpose of this study was to investigate the protective role of furazolidone against the formation of duodenal ulcer induced by cysteamine and the effect of furazolidone on NE, DA and 5-HT concentrations in various brain regions (telencephalon, diencephalon and brainstem)." | 3.67 | [Effects of furazolidone on brain monoamines in the treatment of peptic ulcer]. ( Huang, CW; Zheng, ZT, 1989) |
| "The effect of furazolidone, a monoamine oxidase (MAO) inhibitor, on cysteamine-induced duodenal ulcer and gut catecholamines was studied in rats, since previous reports have suggested protective effects of MAO inhibitors against other forms of experimental mucosal injury." | 3.67 | Effect of furazolidone on gut catecholamine in cysteamine-induced duodenal ulcer in the rat. ( Xing, LP; Zheng, ZT, 1988) |
| "Furazolidone has been effective against Helicobacter pylori in Iran, with no resistance, but with intolerable side effects in the second week." | 2.73 | Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease. ( Agah, S; Ajvadi, Y; Ali-Asgari, A; Ebrahimi-Dariani, N; Khatibian, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Nasseri-Moghaddam, S; Pourshams, A; Sotoudehmanesh, R; Vahedi, H; Zendehdel, N, 2007) |
| "Duodenal ulcers were healed in nine of 10 (90%) patients in the BTF group and in all patients (12/12) (100%) in the OBTM group (P = N." | 2.70 | Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole. ( Domareva, I; Ganskaya, Z; Isakov, V; Koudryavtseva, L; Maev, I, 2002) |
| "Furazolidone was tried in several developing countries and showed good results in some trials." | 1.37 | To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients. ( Hasan, M; Islam, N; Masud, H; Raihan, AS; Roy, PK; Saha, SK, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (15.38) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 11 (42.31) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, Y | 1 |
| Zhu, Y | 1 |
| Zhou, H | 1 |
| Lu, ZF | 1 |
| Yang, Z | 1 |
| Shu, X | 1 |
| Guo, XB | 1 |
| Fan, HZ | 1 |
| Tang, JH | 1 |
| Zeng, XP | 1 |
| Wen, JB | 1 |
| Li, XQ | 1 |
| He, XX | 1 |
| Ma, JH | 1 |
| Liu, DS | 1 |
| Huang, CB | 1 |
| Xu, NJ | 1 |
| Wang, NR | 1 |
| Lu, NH | 1 |
| Li, Y | 1 |
| Wang, XY | 1 |
| Shen, SR | 1 |
| Fakheri, H | 2 |
| Taghvaei, T | 1 |
| Hosseini, V | 1 |
| Bari, Z | 1 |
| Saha, SK | 2 |
| Masud, H | 1 |
| Islam, N | 1 |
| Raihan, AS | 1 |
| Roy, PK | 1 |
| Hasan, M | 1 |
| Isakov, V | 1 |
| Domareva, I | 1 |
| Koudryavtseva, L | 1 |
| Maev, I | 1 |
| Ganskaya, Z | 1 |
| Vasil'ev, IuV | 1 |
| Zvenigorodskaia, LA | 1 |
| Karateev, AE | 1 |
| Nasonov, EL | 1 |
| Radenska-Lopovok, SG | 1 |
| Kawakami, E | 1 |
| Machado, RS | 1 |
| Ogata, SK | 1 |
| Langner, M | 1 |
| Fukushima, E | 1 |
| Carelli, AP | 1 |
| Bonucci, VC | 1 |
| Patricio, FR | 1 |
| Khatibian, M | 2 |
| Ajvadi, Y | 1 |
| Nasseri-Moghaddam, S | 1 |
| Ebrahimi-Dariani, N | 1 |
| Vahedi, H | 2 |
| Zendehdel, N | 1 |
| Sotoudehmanesh, R | 1 |
| Agah, S | 1 |
| Mikaeli, J | 1 |
| Pourshams, A | 1 |
| Ali-Asgari, A | 1 |
| Malekzadeh, R | 3 |
| Massarrat, S | 3 |
| Tovey, FI | 1 |
| Resende, LM | 2 |
| Queiroz, DM | 3 |
| Barbosa, AJ | 1 |
| Mendes, EN | 2 |
| Rocha, GA | 3 |
| Coelho, LG | 4 |
| Passos, MC | 4 |
| Castro, LP | 2 |
| Oliveira, CA | 2 |
| Lima Júnior, GF | 2 |
| Moura, SB | 1 |
| Cunha-Melo, JR | 1 |
| Liu, W | 1 |
| Lü, B | 1 |
| Xiao, S | 1 |
| Liu, WZ | 2 |
| Xiao, SD | 2 |
| Shi, Y | 1 |
| Wu, SM | 1 |
| Zhang, DZ | 1 |
| Xu, WW | 1 |
| Tytgat, GN | 2 |
| Dani, R | 1 |
| Dias, MG | 1 |
| Franco, JM | 1 |
| Magalhães, LC | 1 |
| Mendes, GS | 1 |
| Moreira, LS | 1 |
| De Castro, LP | 1 |
| Toppa, NH | 1 |
| Cabral, MM | 1 |
| Salles, PG | 1 |
| Ansari, R | 1 |
| Siavoshi, F | 1 |
| Alizadeh, BZ | 2 |
| Eshraghian, MR | 1 |
| Vakili, A | 1 |
| Saghari, M | 1 |
| Hu, PJ | 1 |
| Lu, H | 1 |
| Cui, Y | 1 |
| Merat, S | 1 |
| Fazel, A | 1 |
| Mansour-Ghanaei, F | 1 |
| Fallah, MS | 1 |
| Shafaghi, A | 1 |
| Chausson, Y | 2 |
| Costa, EL | 1 |
| Maia, AF | 1 |
| Brandao, MJ | 1 |
| Rodrigues, DC | 1 |
| Castro, Lde P | 1 |
| Ali, BH | 1 |
| Zhang, BM | 1 |
| Song, XR | 1 |
| Huang, CW | 1 |
| Zheng, ZT | 3 |
| Xing, LP | 2 |
15 trials available for furazolidone and Duodenal Ulcer
| Article | Year |
|---|---|
Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Drug Administration Schedule; Drug Therapy, Combin | 2014 |
[Efficacy of 4 kinds of triple strategy for Helicobacter pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer | 2008 |
A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarith | 2012 |
Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Drug Therap | 2002 |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Com | 2002 |
[Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
Topics: Aged; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arth | 2005 |
Furazolidone-based triple therapy for H pylori gastritis in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Child, Preschool | 2006 |
Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; | 2007 |
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithrom | 1996 |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; | 1999 |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Brazil; Clarithromycin; Drug Therapy, C | 1999 |
Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease.
Topics: Adult; Anti-Bacterial Agents; Drug Combinations; Duodenal Ulcer; Female; Furazolidone; Helicobacter | 2000 |
A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Drug Therapy, C | 2000 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithr | 2001 |
Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Duodena | 2002 |
11 other studies available for furazolidone and Duodenal Ulcer
| Article | Year |
|---|---|
To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bangladesh; Drug Therapy, | 2011 |
Treatment of duodenal ulceration with Furazolidine in China preceded the discovery of its association with H pylori.
Topics: Anti-Infective Agents, Local; China; Duodenal Ulcer; Duodenum; Furazolidone; Helicobacter Infections | 2007 |
Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; | 1993 |
Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; | 1993 |
Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study.
Topics: Amoxicillin; Brazil; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; | 1992 |
Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse.
Topics: Adult; Amoxicillin; Breath Tests; Carbon Radioisotopes; Drug Administration Schedule; Drug Therapy, | 1991 |
Effect of nitrofurans on duodenal ulceration induced by cysteamine or indometacin.
Topics: Animals; Anti-Ulcer Agents; Cysteamine; Duodenal Ulcer; Female; Furazolidone; Indomethacin; Nitrofur | 1991 |
[Comparative study of the effect of wei-yan-ning and furazolidone in the treatment of gastritis and gastric ulcer caused by pyloric Campylobacter].
Topics: Adolescent; Adult; Campylobacter Infections; Chronic Disease; Drugs, Chinese Herbal; Duodenal Ulcer; | 1989 |
[Effects of furazolidone on brain monoamines in the treatment of peptic ulcer].
Topics: Animals; Biogenic Monoamines; Brain; Cysteamine; Duodenal Ulcer; Female; Furazolidone; Rats; Rats, I | 1989 |
[Effect of furazolidone on gut catecholamine levels in cysteamine-induced duodenal ulcer in the rat].
Topics: Animals; Catecholamines; Cysteamine; Duodenal Ulcer; Female; Furazolidone; Intestines; Rats; Rats, I | 1988 |
Effect of furazolidone on gut catecholamine in cysteamine-induced duodenal ulcer in the rat.
Topics: Animals; Cysteamine; Dopamine; Dose-Response Relationship, Drug; Duodenal Ulcer; Duodenum; Female; F | 1988 |